Cargando…
Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates
Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix C...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180248/ https://www.ncbi.nlm.nih.gov/pubmed/32132195 http://dx.doi.org/10.1128/JCM.01752-19 |
_version_ | 1783525782906208256 |
---|---|
author | Whitley, Vicki Kircher, Susan Gill, Tracey Hindler, Janet A. O’Rourke, Susan Cooper, Charles Tulpule, Anagha Denys, Gerald A. |
author_facet | Whitley, Vicki Kircher, Susan Gill, Tracey Hindler, Janet A. O’Rourke, Susan Cooper, Charles Tulpule, Anagha Denys, Gerald A. |
author_sort | Whitley, Vicki |
collection | PubMed |
description | Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix CPO detect (CPO detect) detects and classifies carbapenemases in Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa during susceptibility testing. The clinical performance of CPO detect is reported here. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates were evaluated across three sites using CPO detect and a composite reference method (RM); the latter was comprised of the modified carbapenem inactivation method and a MIC screen for ertapenem, imipenem, and meropenem. Multiplex PCR testing was also utilized for Ambler class determination. Positive and negative percentages of agreement (PPA and NPA, respectively) between CPO detect and the RM were determined. The PPA and NPA for Enterobacterales were 98.5% (confidence intervals, 96.6%, 99.4%) and 97.2% (95.8%, 98.2%), respectively. The A. baumannii PPA and NPA, respectively, were 97.1% (90.2%, 99.2%) and 97.1% (89.9%, 99.2%). The P. aeruginosa PPA and NPA, respectively, were 95.9% (88.6%, 98.6%) and 92.3% (86.7%, 95.6%). The PPA values for carbapenemase class designations for all organisms combined and Enterobacterales alone, respectively, were 95.3% (90.2%, 97.8%) and 94.6% (88.8%, 97.5%) for class A, 94.0% (88.7%, 96.6%) and 96.4% (90.0%, 98.8%) for class B, and 95.0% (90.1%, 97.6%) and 99.0% (94.4%, 99.8%) for class D carbapenemases. NPA values for all organisms and Enterobacterales alone ranged from 98.5% to 100%. CPO detect provided accurate detection and classification of CPOs for the majority of isolates of Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa tested. |
format | Online Article Text |
id | pubmed-7180248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-71802482020-04-27 Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates Whitley, Vicki Kircher, Susan Gill, Tracey Hindler, Janet A. O’Rourke, Susan Cooper, Charles Tulpule, Anagha Denys, Gerald A. J Clin Microbiol Bacteriology Limited treatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative bacterial infections. New approaches for carbapenemase-producing organism (CPO) detection may help inform clinician decision-making on patient treatment and infection control. BD Phoenix CPO detect (CPO detect) detects and classifies carbapenemases in Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa during susceptibility testing. The clinical performance of CPO detect is reported here. Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates were evaluated across three sites using CPO detect and a composite reference method (RM); the latter was comprised of the modified carbapenem inactivation method and a MIC screen for ertapenem, imipenem, and meropenem. Multiplex PCR testing was also utilized for Ambler class determination. Positive and negative percentages of agreement (PPA and NPA, respectively) between CPO detect and the RM were determined. The PPA and NPA for Enterobacterales were 98.5% (confidence intervals, 96.6%, 99.4%) and 97.2% (95.8%, 98.2%), respectively. The A. baumannii PPA and NPA, respectively, were 97.1% (90.2%, 99.2%) and 97.1% (89.9%, 99.2%). The P. aeruginosa PPA and NPA, respectively, were 95.9% (88.6%, 98.6%) and 92.3% (86.7%, 95.6%). The PPA values for carbapenemase class designations for all organisms combined and Enterobacterales alone, respectively, were 95.3% (90.2%, 97.8%) and 94.6% (88.8%, 97.5%) for class A, 94.0% (88.7%, 96.6%) and 96.4% (90.0%, 98.8%) for class B, and 95.0% (90.1%, 97.6%) and 99.0% (94.4%, 99.8%) for class D carbapenemases. NPA values for all organisms and Enterobacterales alone ranged from 98.5% to 100%. CPO detect provided accurate detection and classification of CPOs for the majority of isolates of Enterobacterales, Acinetobacter baumannii, and Pseudomonas aeruginosa tested. American Society for Microbiology 2020-04-23 /pmc/articles/PMC7180248/ /pubmed/32132195 http://dx.doi.org/10.1128/JCM.01752-19 Text en Copyright © 2020 Whitley et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Bacteriology Whitley, Vicki Kircher, Susan Gill, Tracey Hindler, Janet A. O’Rourke, Susan Cooper, Charles Tulpule, Anagha Denys, Gerald A. Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title | Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title_full | Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title_fullStr | Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title_full_unstemmed | Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title_short | Multicenter Evaluation of the BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase-Producing Organisms in Clinical Isolates |
title_sort | multicenter evaluation of the bd phoenix cpo detect test for detection and classification of carbapenemase-producing organisms in clinical isolates |
topic | Bacteriology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180248/ https://www.ncbi.nlm.nih.gov/pubmed/32132195 http://dx.doi.org/10.1128/JCM.01752-19 |
work_keys_str_mv | AT whitleyvicki multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT kirchersusan multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT gilltracey multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT hindlerjaneta multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT orourkesusan multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT coopercharles multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT tulpuleanagha multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates AT denysgeralda multicenterevaluationofthebdphoenixcpodetecttestfordetectionandclassificationofcarbapenemaseproducingorganismsinclinicalisolates |